These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. McLean KJ; Munro AW Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141 [TBL] [Abstract][Full Text] [Related]
3. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets? Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776 [TBL] [Abstract][Full Text] [Related]
4. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems. McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138 [TBL] [Abstract][Full Text] [Related]
5. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system. Ortiz de Montellano PR J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets. Hudson SA; McLean KJ; Munro AW; Abell C Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869 [TBL] [Abstract][Full Text] [Related]
7. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169 [TBL] [Abstract][Full Text] [Related]
8. Genetic and mass spectrometric tools for elucidating the physiological function(s) of cytochrome P450 enzymes from Mycobacterium tuberculosis. Ouellet H; Chow ED; Guan S; Cox JS; Burlingame AL; de Montellano PR Methods Mol Biol; 2013; 987():79-94. PubMed ID: 23475669 [TBL] [Abstract][Full Text] [Related]
9. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention. McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022 [TBL] [Abstract][Full Text] [Related]
11. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1. Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461 [TBL] [Abstract][Full Text] [Related]
12. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen. McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780 [TBL] [Abstract][Full Text] [Related]
13. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427 [TBL] [Abstract][Full Text] [Related]
14. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target]. Lu Y; Qiao F; You XF; Yang XY Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457 [TBL] [Abstract][Full Text] [Related]
15. The preponderance of P450s in the Mycobacterium tuberculosis genome. McLean KJ; Clift D; Lewis DG; Sabri M; Balding PR; Sutcliffe MJ; Leys D; Munro AW Trends Microbiol; 2006 May; 14(5):220-8. PubMed ID: 16581251 [TBL] [Abstract][Full Text] [Related]